Xingxing Zang, Ph.D.

Wang, S., Chen, C., Li, M., Qian, J., Sun, F., Li, Y., Yu, M., Wang, M., Zang, X., Zhu, R., Li, D. & Du, M., Jan 1 2019, In : Cell Death and Disease. 10, 1, 15.

Research output: Contribution to journal › Article

Mucin-3

Cytotoxic T-Lymphocytes

Immunoglobulins

Cytokines

T-Lymphocytes

2018 Nobel Prize in medicine awarded to cancer immunotherapy: Immune checkpoint blockade – A personal account

Zang, X., Jan 1 2018, (Accepted/In press) In : Genes and Diseases.

Research output: Contribution to journal › Article

Nobel Prize

Immunotherapy

Medicine

Neoplasms

NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8⁺ T cells for tumor promotion

Li, L., Han, L., Sun, F., Zhou, J., Ohaegbulam, K. C., Tang, X., Zang, X., Steinbrecher, K. A., Qu, Z. & Xiao, G., Feb 26 2018, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journal › Article

Macrophages

T-Lymphocytes

Cytotoxic T-Lymphocytes

Neoplasms

Interleukin-10

PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers

Ying, L., Yan, F., Meng, Q., Yu, L., Yuan, X., Gantier, M. P., Williams, B. R. G., Chan, D. W., Shi, L., Tu, Y., Ni, P., Wang, X., Chen, W., Zang, X., Xu, D. & Hu, Y., Feb 16 2018, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journal › Article

Stomach Neoplasms

Biomarkers

Survival

Tumor Escape

T-Lymphocytes

2 Citations

Wide expression and significance of alternative immune checkpoint molecules, B7x and HHLA2, in PD-L1–negative human lung cancers

Cheng, H., Borczuk, A., Janakiram, M., Ren, X., Lin, J., Assal, A., Halmos, B., Perez-Soler, R. & Zang, X., Apr 15 2018, In : Clinical Cancer Research. 24, 8, p. 1954-1964 11 p.

Research output: Contribution to journal › Article

Lung Neoplasms

Non-Small Cell Lung Carcinoma

Neoplasms

T-Lymphocytes

Immunotherapy